AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
07 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
06 Mar 2002 10:01 AM
RNS
Omeprazole Patent Decision
06 Mar 2002 07:00 AM
RNS
Purchase of Own Securities
28 Feb 2002 01:30 PM
RNS
Report and Accounts Published
28 Feb 2002 12:20 PM
RNS
Annual Report and Accounts
21 Feb 2002 01:00 PM
RNS
Director Shareholding
21 Feb 2002 01:00 PM
RNS
Director Shareholding
21 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
20 Feb 2002 01:00 PM
RNS
Casodex Priority Review
20 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
15 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
14 Feb 2002 05:25 PM
RNS
Dividend
11 Feb 2002 04:00 PM
RNS
Holding(s) in Company
11 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
08 Feb 2002 07:00 AM
RNS
Purchase of Own Securities
05 Feb 2002 04:30 PM
RNS
Director Shareholding
31 Jan 2002 11:05 AM
RNS
Dividend
31 Jan 2002 11:00 AM
RNS
Final Results - Part 2
31 Jan 2002 11:00 AM
RNS
Final Results
30 Jan 2002 09:00 AM
RNS
Notice of Results
28 Dec 2001 02:10 PM
RNS
Regulatory Application-Iressa
17 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
14 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
13 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
12 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
11 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
10 Dec 2001 03:28 PM
RNS
New Data on Arimidex
10 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
07 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
06 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
05 Dec 2001 07:00 AM
RNS
Purchase of Own Securities
04 Dec 2001 04:00 PM
RNS
Director Shareholding
04 Dec 2001 04:00 PM
RNS
Director Shareholding
03 Dec 2001 08:16 AM
RNS
Annual Business Review - Pt 2
03 Dec 2001 08:15 AM
RNS
Annual Business Review - Pt 1
03 Dec 2001 07:01 AM
RNS
Purchase of Own Securities
30 Nov 2001 09:00 AM
RNS
Annual Business Review
30 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
29 Nov 2001 07:01 AM
RNS
Purchase of Own Securities
28 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
26 Nov 2001 03:10 PM
RNS
Zestril Market Exclusivity
26 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
21 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
20 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
19 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
16 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
13 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
12 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
02 Nov 2001 07:00 AM
RNS
Purchase of Own Securities
31 Oct 2001 02:03 PM
RNS
Litigation Announcement
AstraZeneca PLC, known as AZN on the London Stock Exchange (LSE), is an Anglo-Swedish multinational pharmaceutical and biotechnology company. Founded on April 6, 1999, AstraZeneca was formed through the merger of the Swedish Astra AB and the British Zeneca Group. The company's roots trace back to 1913, when Astra AB was established by a group of doctors and apothecaries in Södertälje, Sweden. Throughout the twentieth century, AstraZeneca grew into one of the largest pharmaceutical companies in the world. It has made numerous corporate acquisitions, including Cambridge Antibody Technology (in 2006), MedImmune (in 2007), Spirogen (in 2013) and Definiens (by MedImmune in 2014). Today, AstraZeneca operates in over 100 countries and employs around 83,000 people. As a member of the LSEG, AZN continues to shape the global healthcare landscape. The company is committed to defeating diseases that impact people's health.
UK 100

Latest directors dealings